The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Tatsutani Kristine N since 2013.
The trader's CIK number is 1528831.
At the time of the last reporting, Tatsutani Kristine N was the CSO, SVP of Reg., Clinic & QA of Zeltiq Aesthetics Inc. (stock ticker symbol ZLTQ).
Also see all insider trading activities at Zeltiq Aesthetics Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2013 | ZLTQ | 0 | $0 | 77,709 | $450,233 | 76,630 | $216,693 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2013-08-01 | ZLTQ | Option Ex | 11,352 | 2.83 | 32,080 |
2013-06-17 | ZLTQ | Sale | 11,352 | 8.24 | 93,540 |
2013-08-02 | ZLTQ | Option Ex | 11,352 | 2.83 | 32,080 |
2013-08-01 | ZLTQ | Sale | 11,352 | 7.00 | 79,464 |
2013-06-14 | ZLTQ | Option Ex | 18,540 | 2.83 | 52,394 |
2013-06-14 | ZLTQ | Sale | 14,127 | 5.80 | 81,936 |
2013-04-23 | ZLTQ | Sale | 4,413 | 5.80 | 25,595 |
2013-04-22 | ZLTQ | Option Ex | 5,696 | 2.83 | 16,119 |
2013-04-23 | ZLTQ | Option Ex | 12,119 | 2.83 | 34,296 |
2013-04-22 | ZLTQ | Sale | 6,775 | 4.60 | 31,164 |
2013-04-23 | ZLTQ | Sale | 12,119 | 4.61 | 55,868 |
2013-03-01 | ZLTQ | Option Ex | 2,700 | 2.83 | 7,641 |
2013-03-01 | ZLTQ | Sale | 2,700 | 4.68 | 12,636 |
2013-01-25 | ZLTQ | Sale | 3,520 | 4.60 | 16,191 |
2013-01-25 | ZLTQ | Option Ex | 3,520 | 2.83 | 9,961 |
2013-01-15 | ZLTQ | Option Ex | 7,343 | 2.83 | 20,780 |
2013-01-14 | ZLTQ | Sale | 4,008 | 4.86 | 19,482 |
2013-01-15 | ZLTQ | Sale | 7,343 | 4.68 | 34,357 |
2013-01-14 | ZLTQ | Option Ex | 4,008 | 2.83 | 11,342 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tatsutani Kristine N (CSO, SVP of Reg., Clinic & QA of Zeltiq Aesthetics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.